Page last updated: 2024-08-21

fusarium and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

fusarium has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, J; Liu, YG; Yang, LY; Zhou, B; Zhu, BQ1
Agoglia, L; Alves, J; Araujo, A; Balbi, E; Carius, L; Covelo, M; Enne, M; Gonzalez, AC; Guedes, C; Halpern, M; Martinho, JM; Pacheco, L; Roma, J1

Other Studies

2 other study(ies) available for fusarium and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

ArticleYear
H1-A, a compound isolated from Fusarium oxysporum inhibits hepatitis C virus (HCV) NS3 serine protease.
    Chinese journal of natural medicines, 2016, Volume: 14, Issue:4

    Topics: Enzyme Inhibitors; Fusarium; Hepacivirus; Hepatitis C; Humans; Magnetic Resonance Spectroscopy; Viral Nonstructural Proteins

2016
Cellulitis and nodular skin lesions due to Fusarium spp in liver transplant: case report.
    Transplantation proceedings, 2010, Volume: 42, Issue:2

    Topics: Amphotericin B; Biopsy; Cellulitis; Fusarium; Graft Rejection; Hepatitis C; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycoses; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole

2010